DYNAVAX TECHNOLOGIES CORP — Director's Dealing 2021

Nov 18, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DYNAVAX TECHNOLOGIES CORP (DVAX)
CIK: 0001029142
Period of Report: 2021-11-16

Reporting Person: Janssen Robert (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-16	Common Stock	M	35974	$10.47	Acquired	44250	Direct
2021-11-16	Common Stock	S	35974	$17.1646	Disposed	8276	Direct
2021-11-17	Common Stock	M	53431	$10.47	Acquired	61707	Direct
2021-11-17	Common Stock	S	53431	$17.0742	Disposed	8276	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-16	Stock Option (Right to Buy)	$10.47	M	35974	Disposed	2026-02-21	Common Stock (35974)	Direct
2021-11-17	Stock Option (Right to Buy)	$10.47	M	53431	Disposed	2026-02-21	Common Stock (53431)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $17.01 to $17.27; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax.

F2: This transaction was executed in multiple trades at prices ranging from $16.92 to $17.30; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax.

F3: This option grant will vest over three (3) years with one-third (1/3) of the shares subject to the option vesting twelve months after the grant date, and one thirty-sixth (1/36) of the shares subject to the option vesting on the last day of each month thereafter.

F4: Not applicable